Diverticulitis Disease Market Size, Share, Trends, Strategies, Overview By 2033

Overview and Scope
Diverticulitis disease refers to a medical condition characterized by inflammation or infection of small pouches that develop in the walls of the colon or large intestine. The symptoms of diverticular disease include lower abdominal pain, constipation, diarrhea and rectal bleeding.

Sizing and Forecast
The diverticulitis disease market size has grown rapidly in recent years. It will grow from $1.68 billion in 2023 to $1.85 billion in 2024 at a compound annual growth rate (CAGR) of 10.4%.  The  growth in the historic period can be attributed to aging population, dietary habits, obesity, advancements in medical imaging.

The diverticulitis disease market size is expected to see strong growth in the next few years. It will grow to $2.65 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%.  The growth in the forecast period can be attributed to colonoscopy and endoscopy, increased awareness, minimally invasive procedures, personalized medicine. Major trends in the forecast period include preventive measures, enhanced diagnostic tools, collaborative care models, healthcare policy changes.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/diverticulitis-disease-global-market-report

Segmentation & Regional Insights
The diverticulitis disease market covered in this report is segmented –
1) By Type: Uncomplicated; Complicated
2) By Diagnosis: Computed Tomography (CT) Scan; Ultrasound; Urine Test; Blood Test
3) By Treatment: Medications; Surgery; Supportive care; Penicillin Antibiotic; Antibiotics; Dietary Supplements; Intravenous (IV) Fluids
4) By End-User: Specialty Centers; Hospitals; Research centers

North America was the largest region in the diverticulitis disease market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in diverticulitis disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12990&type=smp

Major Driver Impacting Market Growth
The rising demand for drugs and treatments for digestive disorders is expected to drive the growth of the diverticulitis disease market in the future. Digestive disorders encompass a broad spectrum of conditions affecting the digestive system, responsible for processing and absorbing nutrients from food. Among these disorders, colorectal cancer stands out as a significant contributor to diverticulitis, as it can lead to the formation of diverticula and bacterial stagnation in the colon’s pouches.For instance, data from the International Agency for Research on Cancer, a France-based government agency, suggests a concerning trend in colorectal cancer cases. It is estimated that by 2040, there will be 3.2 million new cases and 1.6 million deaths attributed to colorectal cancer annually. This represents a substantial increase from the 1.9 million newly diagnosed patients and 930,000 deaths reported in 2020.

Key Industry Players
Major players in the diverticulitis disease market are  Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Cipla Limited, Hikma Pharmaceuticals PLC, Endo Pharmaceuticals, Aspen Pharmacare, Zydus Lifesciences, Lupin Limited, Glenmark Pharmaceuticals, Alkem Laboratories, Torrent Pharmaceuticals Ltd.

The diverticulitis disease market report table of contents includes:
               1. Executive Summary

2. Diverticulitis Disease Market Characteristics
3. Diverticulitis Disease Market Trends And Strategies
4. Diverticulitis Disease Market – Macro Economic Scenario
5. Global Diverticulitis Disease Market Size and Growth
6. Diverticulitis Disease Market Segmentation
7. Diverticulitis Disease Market Regional And Country Analysis

…………….

34. Key Mergers And Acquisitions In The Diverticulitis Disease Market
35. Diverticulitis Disease Market Future Outlook and Potential Analysis
36. Appendix

List Of Tables :                    

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

……………

Table 75: Pfizer Inc. Financial Performance

Table 76: Johnson and Johnson Financial Performance

Table 77: F. Hoffmann-La Roche AG Financial Performance

Table 78: Merck & Co. Inc. Financial Performance

Table 79: AbbVie Inc. Financial Performance

Explore the trending research reports from TBRC:

https://topprnews.com/drum-handling-equipment-market-statistics/

https://goodprnews.com/gastrointestinal-stromal-tumor-market-statistics/

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model